Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

BACKGROUND: More accurate risk assessments are needed to improve prostate cancer management. OBJECTIVE: To identify blood-based protein biomarkers that provided prognostic information for risk stratification. DESIGN, SETTING, AND PARTICIPANTS: Mass spectrometry was used to identify biomarker candida...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol Open Sci
Main Authors: Guldvik, Ingrid J., Zuber, Verena, Braadland, Peder R., Grytli, Helene H., Ramberg, Håkon, Lilleby, Wolfgang, Thiede, Bernd, Zucknick, Manuela, Saatcioglu, Fahri, Gislefoss, Randi, Kvåle, Rune, George, Anne, Grönberg, Henrik, Wiklund, Fredrik, Neal, David E., Gnanapragasam, Vincent J., Taskén, Kristin A., Mills, Ian G.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Prostate Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8317831/
https://ncbi.nlm.nih.gov/pubmed/34337468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euros.2020.08.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados